COMMUNIQUÉS West-GlobeNewswire

Cytori Reports Bioequivalence Trial Results in Ovarian Cancer at AAPS

16/11/2017 - 14:00

Pharmacokinetic Bioequivalence Shown for Cytori’s ATI-0918 Liposomal Formulation of Doxorubicin Hydrochloride, Results Presented at the 2017 American Association of Pharmaceutical Scientists Annual Meeting SAN DIEGO, [...]

Prothena Highlights Breadth of Novel Pipeline at R&D Day

16/11/2017 - 14:00

Clinical development programs advancing toward key milestones Dr. Morie Gertz of Mayo Clinic discusses clinical aspects of AL amyloidosis and the role of cardiac biomarker NT-proBNP Novel discovery pipeline in [...]

Innovation Pharmaceuticals Offers Perspectives on Brilacidin as a Potential Preventative Treatment for Oral Mucositis in Head and Neck Cancer Patients

16/11/2017 - 14:00

BEVERLY, Mass., Nov. 16, 2017 (GLOBE NEWSWIRE) -- Innovation Pharmaceuticals Inc. (OTCQB:IPIX) (“the Company”), a clinical stage biopharmaceutical company, is pleased to provide additional perspectives on the planned [...]

Interpace Diagnostics Announces New York State Approval of New Product

16/11/2017 - 14:00

PARSIPPANY, N.J., Nov. 16, 2017 (GLOBE NEWSWIRE) -- Interpace Diagnostics Corp. (NASDAQ: IDXG ), a fully integrated commercial company that provides clinically useful molecular diagnostic tests and pathology services [...]

Sonoma Pharmaceuticals Announces FDA Approval of Expanded Indication for Alevicyn™ to Add Antimicrobial Language

16/11/2017 - 13:45

PETALUMA, Calif., Nov. 16, 2017 (GLOBE NEWSWIRE) -- Sonoma Pharmaceuticals, Inc. (Nasdaq: SNOA, warrants SNOAW), a specialty pharmaceutical company that develops and markets unique and effective solutions for the [...]

KemPharm Completes Successful End-of-Phase 2 Meeting on KP415 with FDA

16/11/2017 - 13:30

All Clinical and Non-Clinical Programs Remain on Track for ADHD Prodrug Candidate, Pivotal Efficacy Trial to Study Duration of Therapy to Initiate Prior to Year-End CORALVILLE, Iowa, Nov. 16, 2017 (GLOBE NEWSWIRE) -- [...]

Stemline Therapeutics Announces Oral Presentation of SL-701 Phase 2 Data in Second-Line Glioblastoma at the 22nd Annual Meeting of the Society of Neuro-Oncology (SNO)

16/11/2017 - 13:00

NEW YORK, Nov. 16, 2017 (GLOBE NEWSWIRE) -- Stemline Therapeutics, Inc. (Nasdaq: STML ), a clinical-stage biopharmaceutical company developing novel therapeutics for difficult to treat cancers, announced today that data [...]

Arcturus Therapeutics Announces Completion of Merger with Alcobra Ltd. and Commences Trading on the Nasdaq Global Market

16/11/2017 - 13:00

Combined Company Commences Trading on the Nasdaq Global Market on November 16, 2017 under the Ticker Symbol “ARCT” Approximately $50.1 Million in Net Cash Following Closing of the Merger Ten (10) Pipeline Programs, Six [...]

MediWound Reports Third Quarter 2017 Financial Results

16/11/2017 - 13:00

NexoBrid ® sales grow 74% year-to-date Raised gross proceeds of $25.2 million through public equity offering Awarded additional $32 million from BARDA to support NexoBrid R&D programs Conference call begins today at [...]

LHC Group and Almost Family Announce Merger of Equals to Create Leading National Provider of In-Home Healthcare Services

16/11/2017 - 12:45

National platform enables greater service and continuity across continuum of care Well-positioned to lead the transition to value-based reimbursement through the highest quality and patient satisfaction Immediately [...]

Purepoint Uranium Group Inc: Hook Lake JV Partners Approve $4 Million For 2018 Exploration Budget

16/11/2017 - 12:45

TORONTO, Nov. 16, 2017 (GLOBE NEWSWIRE) -- Purepoint Uranium Group Inc. (the “ Company ” or “ Purepoint ”) (TSX:PTU.V) announced today that the proposed 2018 Hook Lake JV exploration program with a budgeted cost of $4, [...]

Merit Medical Signs Purchase Agreement with BD for Divestment Assets

16/11/2017 - 12:30

SOUTH JORDAN, Utah, Nov. 16, 2017 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI ), a leading manufacturer and marketer of proprietary disposable devices used in interventional, diagnostic and therapeutic [...]

BioCryst to Present at 29th Annual Piper Jaffray Healthcare Conference

16/11/2017 - 12:00

RESEARCH TRIANGLE PARK, N.C., Nov. 16, 2017 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX ) announced today that executives from the Company are scheduled to provide a corporate summary and update [...]

Orphazyme A/S: Major shareholder announcement

16/11/2017 - 11:06

Company announcement Orphazyme A/S No. 10/2017 Ole Maaløes Vej 3 DK-2200 Copenhagen N www.orphazyme.com Company Registration No. 32266355 16 November 2017 Major shareholder announcement With reference to company [...]

Orphazyme A/S: Reporting of transactions made by persons discharging managerial responsibilities and persons closely associated with them in Orphazymes' shares

16/11/2017 - 10:31

Company announcement Orphazyme A/S No. 9/2017 Ole Maaløes Vej 3 DK-2200 Copenhagen N www.orphazyme.com Company Registration No. 32266355 16 November 2017 Pursuant to the Market Abuse Regulation article 19, Orphazyme A/S [...]

Orphazyme A/S: New share-based incentive programme

16/11/2017 - 09:31

Company announcement Orphazyme A/S No. 8/2017 Ole Maaløes Vej 3 DK-2200 Copenhagen N www.orphazyme.com Company Registration No. 32266355 16 November 2017 With reference to the offering circular (the "Offering Circular [...]

Orphazyme A/S: Stabilisation period begins

16/11/2017 - 09:16

Company announcement Orphazyme A/S No. 7/2017 Ole Maaløes Vej 3 DK-2200 Copenhagen N www.orphazyme.com Company Registration No. 32266355 16 November 2017 NOT FOR RELEASE OR DISTRIBUTION OR PUBLICATION IN WHOLE OR IN [...]

What You Need to Know About Winter Allergies

16/11/2017 - 09:00

ASHEVILLE, N.C., Nov. 16, 2017 (GLOBE NEWSWIRE) -- What’s lurking indoors during the ‘non-allergy’ season? Traditionally, most people associate the spring and fall months with ‘allergy season’. Although trees, grasses [...]

Summit Therapeutics plc : Miscellaneous

16/11/2017 - 08:01

Summit Therapeutics plc ("Summit" or the "Company") SUMMIT APPOINTS PANMURE GORDON AS JOINT BROKER Oxford, UK, 16 November 2017- Summit Therapeutics plc (NASDAQ: SMMT, AIM: SUMM) the drug discovery and development [...]